BDBM50169897 3-{4-[4-Amino-6-(3-chloro-phenylamino)-[1,3,5]triazin-2-yl]-pyridin-2-ylamino}-propan-1-ol::CHEMBL190805

SMILES: Nc1nc(Nc2cccc(Cl)c2)nc(n1)-c1ccnc(NCCCO)c1

InChI Key: InChIKey=GASCNUBLHQPAMW-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50169897   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Vascular endothelial growth factor receptor 2 (Homo sapiens (Human))	BDBM50169897 (3-{4-[4-Amino-6-(3-chloro-phenylamino)-[1,3,5]tria...) Show SMILES Nc1nc(Nc2cccc(Cl)c2)nc(n1)-c1ccnc(NCCCO)c1 Show InChI InChI=1S/C17H18ClN7O/c18-12-3-1-4-13(10-12)22-17-24-15(23-16(19)25-17)11-5-7-21-14(9-11)20-6-2-8-26/h1,3-5,7,9-10,26H,2,6,8H2,(H,20,21)(H3,19,22,23,24,25)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	1.07E+3	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of vascular endothelial growth factor receptor 2				J Med Chem 48: 4535-46 (2005) Article DOI: 10.1021/jm040214h BindingDB Entry DOI: 10.7270/Q2833RK0
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 1 (Homo sapiens (Human))	BDBM50169897 (3-{4-[4-Amino-6-(3-chloro-phenylamino)-[1,3,5]tria...) Show SMILES Nc1nc(Nc2cccc(Cl)c2)nc(n1)-c1ccnc(NCCCO)c1 Show InChI InChI=1S/C17H18ClN7O/c18-12-3-1-4-13(10-12)22-17-24-15(23-16(19)25-17)11-5-7-21-14(9-11)20-6-2-8-26/h1,3-5,7,9-10,26H,2,6,8H2,(H,20,21)(H3,19,22,23,24,25)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	1.11E+3	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of cyclin dependent kinase (CDK1)				J Med Chem 48: 4535-46 (2005) Article DOI: 10.1021/jm040214h BindingDB Entry DOI: 10.7270/Q2833RK0
					More data for this Ligand-Target Pair